We also conclude that whether PACE4 is silenced through molecular interference or inhibited through exogenous pharmacological inhibitors, the tumoral phenotype demonstrates that PACE4 has a key role in regards to cell proliferation, survival and tumor progression in prostate cancer, most likely through the sustained processing of key mitogenic and pro-survival substrates. Here, PCSK6 is linked to neoplasm.